What is the price target for LOVE stock?
5 analysts have analysed LOVE.CA and the average price target is 3.57 CAD. This implies a price increase of 98.33% is expected in the next year compared to the current price of 1.8.
CANNARA BIOTECH INC (LOVE.CA) Forecast, Price Target & Analyst Ratings
TSX-V:LOVE • CA13765U2002
Current stock price
1.8 CAD
-0.03 (-1.64%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CANNARA BIOTECH INC (LOVE.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$3.57
Upside
+ 98.33%
From current price of CA$1.80 to mean target of CA$3.57, Based on 5 analyst forecasts
Low
CA$3.54
Median
CA$3.57
High
CA$3.68
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for LOVE.CA. The average price target is 3.57 CAD. This implies a price increase of 98.33% is expected in the next year compared to the current price of 1.8.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
LOVE.CA was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LOVE.CA.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed LOVE.CA. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-27 | RESEARCH CAPITAL CORPORATION | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 27, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 57.563M 59.91% | 82.15M 42.71% | 107.317M 30.64% | 128.63M 19.86% | 143.31M 11.41% | 174.02M 21.43% | |
| EBITDA YoY % growth | -4.139M -82.76% | -11.154M -169.51% | -1.164M 89.57% | 36.875M 3,269.04% | 41.397M 12.26% | 48.93M 18.20% | |
| EBIT YoY % growth | -9.081M -46.82% | -17.506M -92.79% | -7.849M 55.17% | 28.47M 462.74% | 32.643M 14.66% | 37.434M 14.68% | |
| Operating Margin | -15.78% | -21.31% | -7.31% | 22.13% | 22.78% | 21.51% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.16 60.00% | 0.20 25.00% | 0.27 34.70% |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
39.14%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
18.32%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
34.10%
EBIT Next 5 Year
N/A
CANNARA BIOTECH INC / LOVE.CA Forecast FAQ
When does CANNARA BIOTECH INC (LOVE.CA) report earnings?
CANNARA BIOTECH INC (LOVE.CA) will report earnings on 2026-04-27.
What is the expected long term growth rate for LOVE stock?
The expected long term growth rate for CANNARA BIOTECH INC (LOVE.CA) is 18.32%.